Skip to content

Demonstration Clinical Study on the Advantageous Diseases of Leukodystrophy

Demonstration Clinical Study on the Advantageous Diseases of Leukodystrophy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000494
Enrollment
Unknown
Registered
2024-09-26
Start date
2024-09-30
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Disease

Interventions

Western medicine treatment group:Blepharoplasty
Chinese Medicine External Treatment Group:Blepharoplasty massage combined with herbal eye fumigation
Chinese Medicine Internal Treatment Group:Chinese medicine

Sponsors

Ineye Hospital of Chengdu University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ?Be 18-75 years of age and of either sex; ?Fulfillment of Western diagnostic criteria for dry eye; ?Informed consent and signed the Informed Consent Form.

Exclusion criteria

Exclusion criteria: ?Those who are unable to perform a dry eye examination due to various factors; ?Patients with severe diseases of the liver or renal system or infectious eye diseases; ?Those who are allergic to the medications used in this study; ?Women who are pregnant or breastfeeding; ?Mental illness or intellectual disability; ?Participants in clinical trials of other drugs within the last 3 months. Note: The inclusion and exclusion criteria for eye diseases are based on a single eye i.e. one eye that meets the inclusion criteria can be used as the target eye for observation and the eye that meets the inclusion criteria for both eyes will be included in the eye with the more severe dry eye.

Design outcomes

Primary

MeasureTime frame
Chinese Medical Evidence Scale;Fluorescein Breakup Time ;Ocular Surface Disease Index;

Secondary

MeasureTime frame
Classification of blepharoplasty deficiency;fluorescent staining of the cornea;Schirmer ? test;Tear Meniscus Height;

Countries

China

Contacts

Public ContactXuan Meng

Ineye Hospital of Chengdu University of TCM

373036630@qq.com13808049469

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026